MODERNA INC (MRNA)

US60770K1079 - Common Stock

106.56  -4.03 (-3.64%)

After market: 106.65 +0.09 (+0.08%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

MODERNA INC

NASDAQ:MRNA (3/28/2024, 8:25:31 PM)

After market: 106.65 +0.09 (+0.08%)

106.56

-4.03 (-3.64%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap40.71B
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

MRNA Daily chart

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Cambridge, Massachusetts and currently employs 3,900 full-time employees. The company went IPO on 2018-12-07. The firm is focused on developing messenger ribonucleic acid (mRNA) therapeutics and vaccines. The company is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range spectrum of diseases. The firm's products include Spikevax, the Moderna COVID-19 vaccine (mRNA-1273), a bivalent vaccine targeting the BA.1 Omicron variant, combined with Spikevax (mRNA-1273.214), and bivalent vaccine targeting the BA.4/BA.5 Omicron variants combined with Spikevax (mRNA-1273.222). The company has a development pipeline of 45 development candidates across its 48 development programs, of which 38 are in clinical studies.

Company Info

MODERNA INC

200 Technology Sq

Cambridge MASSACHUSETTS 02139

P: 16177146500

CEO: Stephane Bancel

Employees: 3900

Website: https://www.modernatx.com/

MRNA News

News Image18 hours ago - ChartmillWhat's going on in today's session: S&P500 movers

What's going on in today's session: S&P500 movers

News Image19 hours ago - Market News VideoThursday Sector Laggards: Healthcare, Services
News Image20 hours ago - ChartmillGet insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session.

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

News Imagea day ago - ChartmillGapping S&P500 stocks in Thursday's session

Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends.

News Imagea day ago - InvestorPlace3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition

Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.

News Imagea day ago - The Motley FoolBull Market Buys: 3 Dividend Stocks to Own for the Long Run

Invest in stability, dividends, and growth with these three accomplished real estate operators.

MRNA Twits

Here you can normally see the latest stock twits on MRNA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example